Emergex  Vaccines has extensive international research and development collaborations in the EU, US and Brazil with established collaborations with leading vaccines research bodies, including the Institute of Molecular and Cell Biology (IMCB) of Singapore, Bio-Manguinhos/FioCruz in Brazil, and George Mason University in the US.

Emergex will consider further collaboration and partnerships to accelerate its pipeline of vaccine candidates.

Please contact info@emergexvaccines.com to discuss opportunities with Emergex Vaccines and to arrange a meeting.